PARS Financial Facts

Net loss: -331.48K
Loss from operations: -306.5K
See Full Income Statement

Paid-in capital in excess of par: 212.03M
Cash and cash equivalents: 279.37K
See Full Balance Sheet

Pharmos Corporation (PARS) Earnings

  |   Expand Research on PARS
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate N/A Revenue Growth Rate N/A
Average % Move 1-Wk after EPS N/A Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
10/31/11 Q311 -$0.01N/A N/A N/AN/A N/A Details